Invention Grant
US09243066B2 Use of M-CSF antibodies in the treatment of osteoarthritis or pain
有权
使用M-CSF抗体治疗骨关节炎或疼痛
- Patent Title: Use of M-CSF antibodies in the treatment of osteoarthritis or pain
- Patent Title (中): 使用M-CSF抗体治疗骨关节炎或疼痛
-
Application No.: US14126878Application Date: 2012-07-17
-
Publication No.: US09243066B2Publication Date: 2016-01-26
- Inventor: Stefan Steidl , John Allan Hamilton , Andrew David Cook
- Applicant: Stefan Steidl , John Allan Hamilton , Andrew David Cook
- Applicant Address: AU Victoria DE Planeggi
- Assignee: University of Melbourne,Morpho Sys AG
- Current Assignee: University of Melbourne,Morpho Sys AG
- Current Assignee Address: AU Victoria DE Planeggi
- Agent Paul F. Wiegel
- Priority: EP11174305 20110718
- International Application: PCT/EP2012/063998 WO 20120717
- International Announcement: WO2013/011021 WO 20130124
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/24 ; C07K16/28 ; A61K39/00
Abstract:
The present invention relates generally to a method for the treatment and/or prophylaxis of osteoarthritis (OA) and/or pain. In accordance with the present invention, an antagonist of c-Fms is effective in the treatment of osteoarthritis and/or pain. An antagonist of M-CSF includes, but is not limited to, an antibody that is specific for M-CSF, IL-34 or c-Fms.
Public/Granted literature
- US20140205608A1 Use of c-Fms antagonists Public/Granted day:2014-07-24
Information query
